9 studies found for:    nestorone
Show Display Options
Rank Status Study
1 Completed Study of the Safety, and Sperm and Gonadotropin Suppression of a Contraceptive Gel in Normal Men
Condition: Contraception
Interventions: Drug: Testosterone;   Drug: Nestorone®
2 Completed NES Gel-1, To Evaluate Nestorone Gel in Combination With Testosterone Gel
Condition: Contraception
Interventions: Drug: Nestorone gel;   Drug: Testosterone Gel
3 Recruiting A Study With an Open-Label Active Control to Evaluate the Potential of Nestorone® to Delay Cardiac Repolarization in Healthy Female Volunteers
Condition: Healthy
Interventions: Drug: Supratherapuetic dose of Nestorone;   Drug: Placebo;   Drug: Moxifloxacin
4 Recruiting Evaluate the Pharmacokinetics and Gonadotropin Suppression of Nestorone®-Testosterone (NES/T) Combination Gel in Men
Condition: Healthy
Interventions: Drug: Nestorone® /testosterone gel;   Drug: Testosterone only gel
5 Completed An Open-label Study to Evaluate the Effects of Concurrent Administration of Vaginal Antimycotic Medication Miconazole Nitrate on the Pharmacokinetics of Nestorone and Ethinyl Estradiol Delivered by a Contraceptive Vaginal Ring in Normal Ovulating Women
Condition: Antifungal Drug Adverse Reaction
Intervention: Drug: NES/EE CVR
6 Unknown  Safety and Efficacy of a Contraceptive Vaginal Ring Delivering Nestorone® and Ethinyl Estradiol
Condition: Contraception
Intervention: Drug: NES/EE CVR
7 Completed Study of the Safety, Efficacy and Cycle Control of a Contraceptive Vaginal Ring
Condition: Contraception
Intervention: Drug: 150 mg of Nestorone and 15 mg of ethinyl estradiol (150/15 NES/EE CVR)
8 Completed Effects of Hormonal Contraceptives on Liver Proteins and Coagulation Factors: A Comparison of a Contraceptive Vaginal Ring and an Oral Contraceptive
Condition: Contraception
Intervention: Drug: Nestorone/ethinyl estradiol contraceptive vaginal ring; levonorgestrel/ethinyl estradiol oral contraceptive
9 Active, not recruiting A Dose-finding Study to Evaluate the Effect of a Contraceptive Vaginal Ring, Releasing Nestorone® and Estradiol, on Cycle Control, Ovulation Inhibition, and Pharmacokinetics in Normal Cycling Women
Condition: Suppression of Ovulation
Interventions: Drug: 10 µg/day E2 with NES 200® µg/day;   Drug: 20 µg/day E2 with NES 200® µg/day;   Drug: 40 µg/day E2 with NES 200® µg/day

Indicates status has not been verified in more than two years